Tag: Heather Bresch
Mylan gets favorable court decision in Biogen’s Tecfidera patent case
Dutch generic drugmaker Mylan said that the US District Court for the Northern District of West Virginia has invalidated Biogen's Tecfidera patent U.S. Patent No. ... Read More
Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes
Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations ... Read More